For activated CD8 + T cells, CLDN18 has a synergistic relationship with PRC1, NUF2, KIF11, EXO1, RTKN2, CCNB1 and other marker genes in HCC. The gene discussed is CD8A; the disease is hepatocellular carcinoma.